000 01425 a2200337 4500
005 20250513131930.0
264 0 _c19971209
008 199712s 0 0 eng d
022 _a1077-9450
024 7 _a10.1097/00042560-199701001-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChaisson, R E
245 0 0 _aPrevention of opportunistic infections in the era of improved antiretroviral therapy.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
_c1997
300 _aS14-22 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAIDS-Related Opportunistic Infections
_xepidemiology
650 0 4 _aAnti-Infective Agents
_xadverse effects
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDrug Interactions
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aPatient Compliance
650 0 4 _aRisk Factors
650 0 4 _aSurvivors
700 1 _aMoore, R D
773 0 _tJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
_gvol. 16 Suppl 1
_gp. S14-22
856 4 0 _uhttps://doi.org/10.1097/00042560-199701001-00003
_zAvailable from publisher's website
999 _c9359073
_d9359073